View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Neuroendocrinology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
February 02, 2022
2 min read
Save

Increased oxytocin levels observed in men with hypersexual disorder

Increased oxytocin levels observed in men with hypersexual disorder

Men with hypersexual disorder have higher levels of oxytocin compared with men without the disorder, and behavioral therapy to resolve hypersexual disorder was linked to reductions in oxytocin, according to study data.

SPONSORED CONTENT
January 10, 2022
3 min read
Save

Oral acromegaly therapy maintains efficacy for most initial responders at 62 weeks

Oral acromegaly therapy maintains efficacy for most initial responders at 62 weeks

Nearly all responders to a 26-week course of oral octreotide maintained a biochemical response and symptomatic control of acromegaly at 62 weeks, according to data from the MPOWERED trial.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
January 05, 2022
2 min read
Save

Unvalidated patient-reported outcome measures limit acromegaly, GH studies

Unvalidated patient-reported outcome measures limit acromegaly, GH studies

One-third of acromegaly and growth hormone deficiency studies report discrepancies between patient-reported outcomes and biochemical outcomes, with many using unvalidated and poorly reported outcome measures, data from a meta-analysis show.

SPONSORED CONTENT
January 04, 2022
3 min read
Save

Endocrine conditions common after pediatric brain tumor treatment

Endocrine conditions common after pediatric brain tumor treatment

Electronic health records data from a European cohort suggest endocrine secondary effects after pediatric brain tumor treatment develop within 2 years of diagnosis, including pituitary deficiencies, hypothyroidism and obesity.

SPONSORED CONTENT
January 03, 2022
2 min read
Save

FDA approves levoketoconazole for Cushing’s syndrome

FDA approves levoketoconazole for Cushing’s syndrome

The FDA approved the steroidogenesis inhibitor levoketoconazole for adults with Cushing’s syndrome for whom surgery is not an option or has not been curative, according to an industry press release.

SPONSORED CONTENT
November 22, 2021
2 min read
Save

Multidisciplinary care key in updated pheochromocytoma, paraganglioma guideline

Multidisciplinary care key in updated pheochromocytoma, paraganglioma guideline

People with metastatic pheochromocytomas and paragangliomas should be closely monitored and undergo routine cross-sectional imaging while also being evaluated by a multidisciplinary team, according to a guideline published in Pancreas.

SPONSORED CONTENT
November 01, 2021
4 min read
Save

Updated Cushing’s disease guideline highlights new diagnosis, treatment ‘roadmap’

Updated Cushing’s disease guideline highlights new diagnosis, treatment ‘roadmap’

An updated guideline for the treatment of Cushing’s disease focuses on new therapeutic options and an algorithm for screening and diagnosis, along with best practices for managing disease recurrence.

SPONSORED CONTENT
October 21, 2021
3 min read
Save

Neuroendocrine tumors require individualized treatment approach

Neuroendocrine tumors require individualized treatment approach

Patients with neuroendocrine tumors are at greater risk for cancer-associated death compared with death due to other causes; however, mortality rates vary according to tumor site.

SPONSORED CONTENT
October 11, 2021
1 min read
Save

Dentists, orthodontists play key role in recognizing facial manifestations of acromegaly

Dentists, orthodontists play key role in recognizing facial manifestations of acromegaly

Dentists and orthodontists are uniquely positioned to identify the early facial manifestations of acromegaly, though new survey data suggest more awareness of the condition is needed to improve early diagnoses.

SPONSORED CONTENT
August 26, 2021
2 min read
Save

FDA approves first once-weekly injection for pediatric GH deficiency

FDA approves first once-weekly injection for pediatric GH deficiency

The FDA approved the first once-weekly formulation of somatropin for children with growth hormone deficiency, according to an industry press release.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails